Keywords: آنتی ژن های تومور; Tumor immunity; Cancer immunoprevention; Tumor antigens; Cancer vaccines;
مقالات ISI آنتی ژن های تومور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن های تومور; Cancer immunotherapy; Personalized medicine; Tumor antigens; Predictive biomarkers; Tumor heterogeneity; Adoptive T cell therapy;
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
Keywords: آنتی ژن های تومور; Breast cancer; Tumor antigens; NY-ESO-1; MAGE-A3; PRAME; WT1; Vaccine; Immunotherapy;
Antigenic targets of CAR T Cell Therapy. A retrospective view on clinical trials
Keywords: آنتی ژن های تومور; CARs; Chimeric antigen receptors; Tumor antigens; Immunotherapy; Adoptive T cell transfer;
Is Disease-Specific Immunotherapy a Potential Reality for MDS?
Keywords: آنتی ژن های تومور; Adoptive T cell therapy; BiTE; Chimeric antigen receptor; Immune checkpoints; Tumor antigens;
Mini-reviewMHC class II restricted neoantigen: A promising target in tumor immunotherapy
Keywords: آنتی ژن های تومور; MHC class II restricted neoantigen; CD4+ T cell; Tumor vaccine; Adoptive cell transfer; TCR-T cell; Tumor immunotherapy; mAb; monoclonal antibody; BiTE; bispecific T cell engager; ACT; adoptive cell transfer; TAs; tumor antigens; CTA; cancer-testis Ag; TI
Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group
Keywords: آنتی ژن های تومور; NY-ESO-1; Smoking; NSCLC; Tumor antigens; MAGE-A4 autoantibodies;
Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial
Keywords: آنتی ژن های تومور; Acute myeloid leukemia; Relapse; Azacitidine; Tumor antigens;
Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
Keywords: آنتی ژن های تومور; Exosomes; Genetic engineering; Tumor antigens; CpG DNA; Cancer vaccine; Drug delivery;
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth
Keywords: آنتی ژن های تومور; Plasma membrane vesicle; Protein transfer; Breast cancer; Tumor antigens; Vaccine;
Anti-HE4 antibodies in infertile women and women with ovarian cancer
Keywords: آنتی ژن های تومور; Cancer diagnostics; Inflammation; Tumor antigens;
Réponse immunitaire et cancers colorectaux
Keywords: آنتی ژن های تومور; immunité spécifique; Lymphocytes infiltrants; Antigènes tumoraux; Instabilité microsatellitaire; Cancers colorectaux; specific immunity; tumor infiltrating lymphocyte; tumor antigens; microsatellite instability; colorectal cancers;
Vaccines in non-small cell lung cancer: Rationale, combination strategies and update on clinical trials
Keywords: آنتی ژن های تومور; Non-small cell lung cancer; Vaccine therapy; Tumor antigens; Adjuvant vaccines
Increasing vaccine potency through exosome antigen targeting
Keywords: آنتی ژن های تومور; TAA; tumor associated antigens; APC; antigen presenting cells; ECD; extracellular domain; CEA; carcinoembryonic antigen; HER2; human epidermal growth factor receptor 2; MUC1; mucin 1; CDC; complement-dependent cytotoxicity; bmDC; bone marrow derived dendr
Impact of radiofrequency ablation on PBMC subpopulation in patients with renal cell carcinoma
Keywords: آنتی ژن های تومور; Radiofrequency ablation; Renal cell carcinoma; Tumor antigens; Lymphocytes activation; Immunotherapy
A simple competitive assay to determine peptide affinity for HLA class II molecules: A useful tool for epitope prediction
Keywords: آنتی ژن های تومور; Class II HLA; T cell epitopes; Tumor antigens; Peptide affinity; Competition assay;
Autoantibodies against tumor-related antigens: Incidence and biologic significance
Keywords: آنتی ژن های تومور; Autoantibodies; Tumor antigens; Human seronome; Tumor immunology
T-cell-based Therapies for Malignancy and Infection in Childhood
Keywords: آنتی ژن های تومور; Hematopoietic stem cell transplantation; Pediatrics; Adoptive immunotherapy; Tumor vaccines; Tumor antigens; Lymphopenia; Immune reconstitution; Chimeric antigen receptor;
Immunotherapy for head and neck cancer
Keywords: آنتی ژن های تومور; Cancer vaccines; Tumor antigens; Immunotherapy; Dendritic cells; Cytokines
Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis
Keywords: آنتی ژن های تومور; Tumor antigens; Immunotherapy; Gene expression profiling; ESTs; FAM46D
Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays
Keywords: آنتی ژن های تومور; Serum and plasma profiling; Data normalization; Tumor antigens; ELISA; IgG; Validation
A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth
Keywords: آنتی ژن های تومور; Tumor antigens; Anti-cancer immunity; Immune tolerance; Autoantibodies; Inflammation
Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: Associations with organ manifestations, immunolaboratory markers and disease activity indices
Keywords: آنتی ژن های تومور; Systemic sclerosis; Systemic lupus erythematosus; Tumor antigens; Clinical manifestations; Disease activity
The use of dendritic cells in cancer immunotherapy
Keywords: آنتی ژن های تومور; Dendritic cells; Cancer vaccines; Tumor antigens; Tolerance; Immunity
Specificity in cancer immunotherapy
Keywords: آنتی ژن های تومور; Cancer immunotherapy; Tumor antigens; Specificity; Glycosylation; Cosmc
Cancer vaccines: Accomplishments and challenges
Keywords: آنتی ژن های تومور; Tumor antigens; Adjuvants; T cells; Antibodies; Immunotherapy
Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells
Keywords: آنتی ژن های تومور; Whole-cell panning; Negative selection; Tumor antigens; Antibodies; Metastasis
Immunotherapy with dendritic cells for cancer
Keywords: آنتی ژن های تومور; Dendritic cells; Immunotherapy; Tumor antigens; Tolerance; Toll-like receptors; Cytokines
Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding to their pathological features
Keywords: آنتی ژن های تومور; BCC, basal cell carcinoma; CRC, colorectal cancer; EB, ethidium bromide; GI, gastrointestinal; MAD, mitotic arrest deficient; RT-PCR, reverse transcriptase polymerase chain reaction; SCC, squamous cell carcinomaCancer–testis genes; TSGA10; Tumor antigens;
Complement as effector system in cancer immunotherapy
Keywords: آنتی ژن های تومور; Complement activation; Tumor antigens; Anti-tumor antibodies; Membrane-complement regulatory proteins
Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera
Keywords: آنتی ژن های تومور; Tumor antigens; IgG antibody reactions; SEREX; Polycythemia vera; Myeloproliferative diseases
Interferon-gamma expressing EBV LMP2A-specific T cells for cellular immunotherapy
Keywords: آنتی ژن های تومور; EBV; Iimmunotherapy; T cells; Interferon-gamma; Tumor antigens; Hodgkin’s lymphoma
Mobilizing the low-avidity T cell repertoire to kill tumors
Keywords: آنتی ژن های تومور; TCR–peptide–MHC affinity; Vaccines; Tumor antigens; T cell tolerance; Functional avidity
A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display
Keywords: آنتی ژن های تومور; Abs, antibodies; TAA, tumor-associated antigenBreast cancer; Immune response; Tumor antigens
Large-scale chemoenzymatic synthesis of blood group and tumor-associated poly-N-acetyllactosamine antigens
Keywords: آنتی ژن های تومور; Poly-N-acetyllactosamines; Oligosaccharides; Chemoenzymatic synthesis; Glycosyltransferases; Blood group; Tumor antigens
Model of stimulation-responsive splicing and strategies in identification of immunogenic isoforms of tumor antigens and autoantigens
Keywords: آنتی ژن های تومور; Alternative splicing; Stimulation-responsive splicing; Autoantigens; Tumor antigens; SEREX cloning; Database mining
Presence and Prognostic Significance of Melanoma-Associated Antigens CYT-MAA and HMW-MAA in Serum of Patients with Melanoma
Keywords: آنتی ژن های تومور; biomarkers; cancer vaccine; tumor antigens;